Edition:
India

Origo Acquisition Corp (OACQ.OQ)

OACQ.OQ on NASDAQ Stock Exchange Capital Market

10.70USD
16 Nov 2017
Change (% chg)

-- (--)
Prev Close
$10.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,318
52-wk High
$11.50
52-wk Low
$10.10

Latest Key Developments (Source: Significant Developments)

CB Pharma Acquisition gets extension to complete initial business combination
Friday, 10 Jun 2016 

CB Pharma Acquisition Corp: CB Pharma Acquisition Corp. announces approval of proposals to extend time to complete initial business combination . Company now has until December 12, 2016 to complete initial business combination . Edward J. Fred appointed as Chief Executive Officer; Jose M. Aldeanueva appointed Chief Financial Officer .Lindsay Rosenwald, Michael Weiss, George Avgerinos, Adam Chill, Arthur Kornbluth, Neil Herskowitz resigned as an officer and/or director.  Full Article

BRIEF-Origo says co, units executed 1st amendment to merger agreement to amend & restate certain terms and provision

* Origo - ‍on Sept 27, co, units executed first amendment to merger agreement to amend and restate certain terms and provision of merger agreement​

No consensus analysis data available.